vTv Therapeutics Inc. Quarterly Depreciation in USD from Q1 2015 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
vTv Therapeutics Inc. quarterly/annual Depreciation history and growth rate from Q1 2015 to Q1 2024.
  • vTv Therapeutics Inc. Depreciation for the quarter ending March 31, 2024 was $22K, unchanged year-over-year.
  • vTv Therapeutics Inc. annual Depreciation for 2023 was $90K, a 2.17% decline from 2022.
  • vTv Therapeutics Inc. annual Depreciation for 2022 was $92K, a 3.37% increase from 2021.
  • vTv Therapeutics Inc. annual Depreciation for 2021 was $89K, a 5.32% decline from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $22K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $22K -$1K -4.35% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $23K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $23K -$4K -14.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $27K +$19K +238% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q1 2019 $8K -$34K -81% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $42K -$10K -19.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q1 2017 $52K -$27K -34.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q1 2016 $79K -$54K -40.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q1 2015 $133K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.